LCID, ASBP, WLDS Stocks Hit 52-Week Lows: What Drove The Selloff?

• Lucid fell more than 7.5% on Monday, extending a five-day decline to a 52-week low of $6.75 after recent financing announcements and the appointment of a new CEO.
• Aspire Biopharma declined to a low of $0.22 after announcing an additional $22.5 million credit line to fund an acquisition.
• Wearable Devices fell to a low of $1.10 after the company entered a warrant inducement agreement for $5 million.

Lucid Group Inc. (LCID), Aspire Biopharma Holdings Inc. (ASBP) and Wearable Devices Ltd. (WLDS) stocks slipped to fresh intraday lows on Monday, with all three companies recording new 52-week lows.

The declines came amid leadership uncertainty, financing concerns, and downward revisions to price targets from Wall Street analysts, which weighed on investor sentiment.

Lucid Drops On Financing, Leadership Concerns

Shares of electric car manufacturer Lucid fell more than 7.5% on Monday, extending a five-day decline, as it fell to a 52-week low of $6.75. The drop followed recent financing decisions and the appointment of a new CEO.

Last week, Lucid announced a $1.05 billion capital raise, including a pricing of its $300 million registered offering of common stock. The company also appointed Silvio Napoli as the new CEO.

However, the company’s shares edged up after the market closed on Monday following Uber Technologies (UBER) saying it had raised its stake in the EV company to 11.5%.

Amid these announcements, the stock also garnered attention from Wall Street analysts, with TD Cowen and Baird lowering price targets on the company. TD Cowen cut Lucid’s price target to $10 from $19 and kept a ‘Hold’ rating on the shares, while Baird lowered the price target on Lucid to $12 from $14 and maintained a ‘Neutral’ rating on the shares.

On Stocktwits, retail sentiment around LCID stock remained in the ‘extremely bullish’ territory at the time of writing, amid ‘extremely high’ message volumes. LCID shares have declined more than 39% this year.

Aspire Biopharma Slips On Financing Concerns

ASBP stock declined for four straight days, slipping to a low of $0.22 on Monday after it announced it had closed the final tranche of a $21 million private placement and secured an additional $22.5 million credit line to fund the acquisition of Dura Control Systems.

On Stocktwits, retail sentiment around ASBP stock improved from ‘bullish’ to the ‘extremely bullish’ territory over the past day, amid ‘extremely high’ message volumes. ASBP shares have declined more than 95% this year.

WLDS Falls On Warrant Inducement

Shares of Wearable Devices Ltd. (WLDS) fell to a low of $1.10 on Monday after the company entered a warrant inducement agreement for $5 million that it said it would use for working capital requirements and other general corporate purposes.

The company also announced a collaboration with Meta-Bounds Inc. to develop intuitive neural control for augmented reality glasses, although it failed to address investor concerns about dilution and funding needs.

On Stocktwits, retail sentiment around WLDS stock improved from ‘neutral’ to the ‘extremely bullish’ territory over the past day, amid ‘extremely high’ message volumes. WLDS shares have declined more than 65% this year.

For updates and corrections, email newsroom[at]stocktwits[dot]com.